![Predictive value of serological factors, maximal standardized uptake value and ratio of Ki67 in patients diagnosed with non‑Hodgkin's lymphoma Predictive value of serological factors, maximal standardized uptake value and ratio of Ki67 in patients diagnosed with non‑Hodgkin's lymphoma](https://www.spandidos-publications.com/article_images/ol/20/4/ol-20-04-11906-g01.jpg)
Predictive value of serological factors, maximal standardized uptake value and ratio of Ki67 in patients diagnosed with non‑Hodgkin's lymphoma
![Survival in B-cell primary ocular lymphoma 1997–2014: a population-based study | Journal of Investigative Medicine Survival in B-cell primary ocular lymphoma 1997–2014: a population-based study | Journal of Investigative Medicine](https://jim.bmj.com/content/jim/66/8/1133/F2.large.jpg?width=800&height=600&carousel=1)
Survival in B-cell primary ocular lymphoma 1997–2014: a population-based study | Journal of Investigative Medicine
![Age-standardized incidence and mortality rates of Hodgkin's lymphoma... | Download Scientific Diagram Age-standardized incidence and mortality rates of Hodgkin's lymphoma... | Download Scientific Diagram](https://www.researchgate.net/publication/337365816/figure/fig2/AS:963539879608324@1606737217071/Age-standardized-incidence-and-mortality-rates-of-Hodgkins-lymphoma-a-and.png)
Age-standardized incidence and mortality rates of Hodgkin's lymphoma... | Download Scientific Diagram
Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial | Haematologica
![Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study - eClinicalMedicine Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study - eClinicalMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/661cfda4-cb2f-4b37-a52b-fc1ad3d7427e/gr1_lrg.jpg)
Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study - eClinicalMedicine
![Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience | Blood Cancer Journal Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-020-0299-0/MediaObjects/41408_2020_299_Fig1_HTML.png)
Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience | Blood Cancer Journal
![A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era | Scientific Reports A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-61378-4/MediaObjects/41598_2020_61378_Fig1_HTML.png)
A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era | Scientific Reports
![Frontiers | Survival Trends in Patients Under Age 65 Years With Mantle Cell Lymphoma, 1995–2016: A SEER-Based Analysis | Oncology Frontiers | Survival Trends in Patients Under Age 65 Years With Mantle Cell Lymphoma, 1995–2016: A SEER-Based Analysis | Oncology](https://www.frontiersin.org/files/Articles/588314/fonc-10-588314-HTML/image_m/fonc-10-588314-g001.jpg)
Frontiers | Survival Trends in Patients Under Age 65 Years With Mantle Cell Lymphoma, 1995–2016: A SEER-Based Analysis | Oncology
![Survival in B-cell primary ocular lymphoma 1997–2014: a population-based study | Journal of Investigative Medicine Survival in B-cell primary ocular lymphoma 1997–2014: a population-based study | Journal of Investigative Medicine](https://jim.bmj.com/content/jim/66/8/1133/F1.large.jpg?width=800&height=600&carousel=1)
Survival in B-cell primary ocular lymphoma 1997–2014: a population-based study | Journal of Investigative Medicine
![High-Dose Chemotherapy Followed by Autologous Stem Cell Rescue for Refractory Hodgkin's Disease and Non-Hodgkin's Lymphoma A. P. Rapoport, J. M. Rowe, and J. F Dipersio In: Zander AR, Barlogie B (eds) Autologus Bone Marrow ... High-Dose Chemotherapy Followed by Autologous Stem Cell Rescue for Refractory Hodgkin's Disease and Non-Hodgkin's Lymphoma A. P. Rapoport, J. M. Rowe, and J. F Dipersio In: Zander AR, Barlogie B (eds) Autologus Bone Marrow ...](http://m.science-connections.com/trends/human_leukemia/image/109.htm1.jpg)
High-Dose Chemotherapy Followed by Autologous Stem Cell Rescue for Refractory Hodgkin's Disease and Non-Hodgkin's Lymphoma A. P. Rapoport, J. M. Rowe, and J. F Dipersio In: Zander AR, Barlogie B (eds) Autologus Bone Marrow ...
The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project | Haematologica
![Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups | Blood Cancer Journal Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups | Blood Cancer Journal](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41408-020-00340-z/MediaObjects/41408_2020_340_Fig2_HTML.png)
Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups | Blood Cancer Journal
![The Revised International Prognostic Index (R-IPI) Score Is Predictive Of Survival In Aggressive Transformed Lymphomas (TL) From Low Grade Non-Hodgkin Lymphomas In The Chemoimmunotherapy Era - ScienceDirect The Revised International Prognostic Index (R-IPI) Score Is Predictive Of Survival In Aggressive Transformed Lymphomas (TL) From Low Grade Non-Hodgkin Lymphomas In The Chemoimmunotherapy Era - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497119675464-fx1.jpg)
The Revised International Prognostic Index (R-IPI) Score Is Predictive Of Survival In Aggressive Transformed Lymphomas (TL) From Low Grade Non-Hodgkin Lymphomas In The Chemoimmunotherapy Era - ScienceDirect
![A) Progression-free Survival and (B) Overall Survival for Patients with... | Download Scientific Diagram A) Progression-free Survival and (B) Overall Survival for Patients with... | Download Scientific Diagram](https://www.researchgate.net/profile/Masoud-Sadeghi/publication/301484619/figure/fig1/AS:352575053418496@1461071851718/A-Progression-free-Survival-and-B-Overall-Survival-for-Patients-with-B-cell.png)